Relationship of Growth Differentiation Factor-15, E-Cadherin, Galectin-3, and Psychological Stress with Quality of Life and Prostate Size in Benign Prostatic Hyperplasia

Objective: Inflammation and oxidative stress are involved in the pathogenesis of benign prostatic hyperplasia (BPH). The relationship of psychological stress, oxidative stress, and inflammation with prostate enlargement is unclear. The objective of the study was to investigate the relationship of growth differentiation factor-15 (GDF-15), E-cadherin, galectin-3 and psychological stress with quality of life (QOL) and prostate size in BPH patients. Methods: Eighty-two BPH cases were included in the study. Growth differentiation fac tor-15, galectin-3, and E-cadherin were analyzed in all the subjects. Perceived Stress Scale-10 (PSS-10) was used to analyse psychological stress. Quality of life score due to urinary symptoms was based on a single question recommended by the International Consensus Committee, and its answer range from delighted (score-0) to terrible (score-6) Results: E-cadherin (P = .014), galectin-3 (P = .004), QOL score (P = .024) and PSS-10 score (P = .001) were higher in BPH cases with increased prostate size. Growth differentia tion factor-15 was lower in BPH patients with higher PSS-10 score (P = .036) and higher QOL score (P = .016). Growth differentiation factor-15 was negatively associated with International Prostate Symptom Score (IPSS) score (r = −0.314, P = .004), QOL (r = −0.284, P = .009), and PSS-10 score (r = −0.031, P = .001). Prostate size was positively associ ated with E-cadherin (r = 0.317, P = .003), galectin-3 (r = 0.243, P = .026), IPSS (r = 0.301, P = .005) and QOL score (r = 0.237, P = .030). Also, a significant correlation was observed between E-cadherin and galectin-3 (r = 0.292, P = .007). Growth differentiation factor-15 (P = .018) and E-cadherin (P = .029) were found to predict QOL and E-cadherin (P = .013) was found to predict prostate size in BPH. Conclusion: E-cadherin can predict prostate enlargement and along with GDF-15, can predict QOL in BPH. Cite this article as: Balamurali P, Nandeesha H, Sreenivasan SK. Relationship of growth differentiation factor-15, E-cadherin, galectin-3, and psychological stress with quality of life and prostate size in benign prostatic hyperplasia. Urol Res Pract. 2025;51(5):173-178.

Authors

Institutions

Publication Details

Journal
Urology Research and Practice
Published
2025-12-05
DOI
https://doi.org/10.5152/tud.2025.24189
Primary Topic
GDF15 and Related Biomarkers
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Relationship of Growth Differentiation Factor-15, E-Cadherin, Galectin-3, and Psychological Stress with Quality of Life and Prostate Size in Benign Prostatic Hyperplasia

PD Balamurali, Sreerag Kodakkattil Sreenivasan, Hanumanthappa Nandeesha
Urology Research and Practice
GDF15 and Related Biomarkers
article

Relationship of Growth Differentiation Factor-15, E-Cadherin, Galectin-3, and Psychological Stress with Quality of Life and Prostate Size in Benign Prostatic Hyperplasia

PD Balamurali, Sreerag Kodakkattil Sreenivasan, Hanumanthappa Nandeesha
article en

Abstract

Objective: Inflammation and oxidative stress are involved in the pathogenesis of benign prostatic hyperplasia (BPH). The relationship of psychological stress, oxidative stress, and inflammation with prostate enlargement is unclear. The objective of the study was to investigate the relationship of growth differentiation factor-15 (GDF-15), E-cadherin, galectin-3 and psychological stress with quality of life (QOL) and prostate size in BPH patients. Methods: Eighty-two BPH cases were included in the study. Growth differentiation fac tor-15, galectin-3, and E-cadherin were analyzed in all the subjects. Perceived Stress Scale-10 (PSS-10) was used to analyse psychological stress. Quality of life score due to urinary symptoms was based on a single question recommended by the International Consensus Committee, and its answer range from delighted (score-0) to terrible (score-6) Results: E-cadherin (P = .014), galectin-3 (P = .004), QOL score (P = .024) and PSS-10 score (P = .001) were higher in BPH cases with increased prostate size. Growth differentia tion factor-15 was lower in BPH patients with higher PSS-10 score (P = .036) and higher QOL score (P = .016). Growth differentiation factor-15 was negatively associated with International Prostate Symptom Score (IPSS) score (r = −0.314, P = .004), QOL (r = −0.284, P = .009), and PSS-10 score (r = −0.031, P = .001). Prostate size was positively associ ated with E-cadherin (r = 0.317, P = .003), galectin-3 (r = 0.243, P = .026), IPSS (r = 0.301, P = .005) and QOL score (r = 0.237, P = .030). Also, a significant correlation was observed between E-cadherin and galectin-3 (r = 0.292, P = .007). Growth differentiation factor-15 (P = .018) and E-cadherin (P = .029) were found to predict QOL and E-cadherin (P = .013) was found to predict prostate size in BPH. Conclusion: E-cadherin can predict prostate enlargement and along with GDF-15, can predict QOL in BPH. Cite this article as: Balamurali P, Nandeesha H, Sreenivasan SK. Relationship of growth differentiation factor-15, E-cadherin, galectin-3, and psychological stress with quality of life and prostate size in benign prostatic hyperplasia. Urol Res Pract. 2025;51(5):173-178.

Urology Research and PracticeVol. 51(5)
Jawaharlal Institute of Post Graduate Medical Education and Research (IN)
Openalex Percentile: Top 45%
GDF15 and Related Biomarkers
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.